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Abstract 
 
Research has shown bacterial vaginosis to be one of the most common vaginal disorders 
in women of child bearing age (Chen, Tian, & Beigi, 2009; Centers for Disease Control, 
2012; Menard, 2011).  Each year many women are seen by their gynecologist, sexually 
transmitted infection (STI) clinics, and emergency rooms (ER) for complaints of having 
malodorous discharge (Bradshaw, et al., 2005). Several STI’s and adverse pregnancy 
outcomes have been attributed to women having bacterial vaginosis (Bradshaw, et al, 
2005; Chen, et al.2009; Elkins, & Mayeaux, 2010).  Women are predisposed to bacterial 
vaginosis by the use of wearing non cotton underwear, douching, having multiple sex 
partners, not using condoms, or not adhering to or complying with the recommended 
treatment regimens. Each year non- adherence to medications cost the US billions of 
dollars.  
Purpose 
This project was to (a) evaluate patients’ knowledge regarding bacterial vaginosis 
prevention and treatment regimens, (b) and attempt to increase patients’ knowledge as a 
result of training of providers.   
Methods 
A quasi-experimental approach was utilized using a comparative change model at 
two different Planned Parenthood health centers.  The project was conducted Monday 
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through Saturday enrolling 50 women diagnosed with bacterial vaginosis.  One clinic was 
randomly selected for providers to receive the 45 minute in-service training, and the other 
clinic’s providers did not receive the in-service training. Subjects were asked to complete 
two surveys.  The first survey consisted of 6 questions which were administered after 
their diagnosis for bacterial vaginosis and consent obtained which took no longer than 3-
4 minutes to complete. Nine to 14 days after the initial visit a second survey was 
administered by phone by the researcher and assistants. 
Results 
The intervention group has a lower median adherence score compared to the 
control group (p<.002) which indicates that the intervention group has better adherence to 
their Flagyl and Metro Gel medication. 
Adherence of wearing thong and cotton underwear was assessed as a yes/no 
variable by intervention status using Fisher’s Exact Test instead of Pearson’s Chi-Square 
given small cell size. 
There was no significant difference between the intervention and control group 
(p>0.05) in regards to thong or cotton underwear adherence. 
Conclusion 
There was an increase in patients’ knowledge regarding adhering to treatment 
regimens; however, there were no significant change in behavior.  
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Introduction 
 Research has shown bacterial vaginosis to be one of the most common vaginal 
disorders in women of child bearing age (Chen, Tian, & Beigi, 2009; Centers for Disease 
Control, 2012; Menard, 2011).   Each year many women are seen by their gynecologist, 
sexually transmitted infection (STI) clinics, and emergency rooms (ER) for complaints of 
having malodorous discharge (Bradshaw, et al., 2005). Several STI’s and adverse 
pregnancy outcomes has been attributed to women having bacterial vaginosis (Bradshaw, 
et al, 2005; Chen, et al.2009; Elkins, & Mayeaux, 2010).  The etiology of bacterial 
vaginosis continues to be misunderstood. Approximately 45% of all women seen and 
diagnosed with symptomatic abnormal vaginal discharges are due to this clinically mild 
disease. Koumans, Sternberg, Bruce, McQuillan, Kendrick, Sutton, & Markowitz, 2007; 
Menard, 2011; Elkins & Mayeaux, 2010 have stated that many women self- medicate 
their vaginal discharge with anti-fungal medications.  
Statement of Purpose 
The purpose of this project was to evaluate patients’ knowledge regarding 
bacterial vaginosis prevention and treatment regimens, and attempt to increase patients’ 
knowledge as a result of training of providers.  Specifically, there will be a greater effect 
on the intervention group receiving education from the health care providers who have 
received additional in-servicing regarding bacterial vaginosis compared with standard 
patient care with patients receiving discharge instructions from the educators or nurse 
practitioner but who have not received additional training.  
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Significance of Study 
Research and data statistics from the National Health and Nutrition Examination 
Survey showed that the United States continues to linger in healthcare when it comes to 
decreasing the recurrence of bacterial vaginosis. (Koumans et al. , 2007).  Data from the 
2001-2002 showed bacterial vaginosis to be very common among women of child 
bearing ages (Koumans et al., 2007; Allsworth, & Peipert, 2007). Annually in the United 
States (U.S.) and Canada the prevalence rates are approximately 4-23% of private 
gynecological patients (higher in lower incomes and African American race), 10% to 
30% of pregnant women and 12% to 61% of women are seen at clinics for vaginal 
discharge or sexually transmitted diseases (Yuden, & Money, 2008). “Research shows 
women diagnosed with bacterial vaginosis have an overgrowth of vaginal anaerobes or 
Gran – negative bacterial”, (Menard, 2011, p. 295). Research has shown that more than 
fifty percent of women diagnosed with bacterial vaginosis are asymptomatic (Donders, 
2010; Menard, 2011).  Microbiological diagnostic testing method is necessary, such as 
Nugent’s scoring system, which is considered the gold standard for diagnosis of having 
bacterial vaginosis (Donders, 2010; Menard, 2011).  According to the CDC 2012 many 
women diagnosed with bacterial vaginosis often have complaints of having a malodorous 
discharge, pain with intercourse, itching, and/or burning (CDC, 2012; Menard, 2011). 
Untreated bacterial vaginosis can lead to several unfavorable patient outcomes such as 
increased risk of sexually transmitted infections (HIV, Chlamydia, Gonorrhea, and 
herpes), preterm labor, and premature infants or births (Menard, 2011; CDC, 2012; 
Koumans et al, 2007; Allsworth, & Peipert, 2007) 
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Project Rationale 
Providers have voiced concerns about seeing patients multiple times for recurrent 
bacterial vaginosis. At the end of each patient’s health visit they are given an approved 
handout from the health clinic, clinician or health educator.  Many patients seen at the 
health centers have been diagnosed and treated several times for recurrent bacterial 
vaginosis. Many patients have voiced concerns as to receiving written materials but no 
one has educated them verbally on ways to decrease or change behavioral practices that 
increase their risk for acquiring bacterial vaginosis. Written and verbal instructions 
remain to be two of the most common forms of communication when relaying drug 
information to patients (Pharm, Pierce, & Muhlbaier, 2013).   Research has proven that 
many “patients don’t understand the written instructions given to them with their 
prescriptions” (Pharm, Pierce, & Muhlbaier, 2013, p 1).    There are several reasons cited 
by the patients for recurrence such as non-adherence to treatment regimens and/or 
behavioral practices. In 2011, Brown, & Bussell reported that 50 percent of patients don’t 
take their medications as ordered.   
Project Purpose 
The purpose of the project was to evaluate patients’ knowledge regarding 
bacterial vaginosis prevention, treatment regimens, and attempt to increase patients’ 
knowledge as a result of training of nurse practitioners and health educators.   
Specifically, it was hypothesized that there would be a greater reduction in risk behaviors 
related to bacterial vaginosis (increased condom use, reduced wearing of thongs, less 
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frequent douching, less use of scented tampons or pads) and more consistent adherence to 
the medication regimens in women whose providers received an additional in-service. 
Several studies have been conducted relating to ways to increase adherence to treatment 
regimens. Today just about everyone has access to computers, cell phones or the internet. 
In 2014 Lunny and colleagues concluded that text messaging can play a substantial 
important  role in notifying patients of doctors’ appointments, STI retesting, provisions of 
STI results, and help improve and facilitate patient communication among patients and 
health care providers.  In 2006, the Institute of Medicine (IOM) wrote a report 
emphasizing the importance of educating patients regarding the importance of adhering 
to their prescribe regimen. Annually approximately 1.5 million people are affected by 
adverse effects of medications simply due to misunderstanding drug information and the 
importance of adherence to treatment regimens (Pharm et al., 2011).  A statement issued 
by the World Health Organization (WHO) in 2003, characterized poor adherence to 
treatment as a worldwide problem affecting developing, as well as developed countries 
(Brown, & Bussell, 2011).  It is estimated that one third to one half of patients are not 
taking their medications as prescribed (Kirpalani, Yaom, & Hayes, 2007; Haynes, .et al, 
2005). Annually, the US loses approximately $100-$289 billion due to patients being 
non-adherent to medication (Ho, 2009; Levine, 2013).  World Health Organization 
considers adherence to be the single modifiable factor that compromises treatment 
outcomes across diseases (Brown, & Bussell, 2011; Au-Yeung, 2011). Patients have 
shared several reasons to their health care providers for not taking, adhering to or 
completing prescribed medications, including“(1) forgetfulness (30%), (2) other priorities 
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(16%), (3) deliberate decision to omit doses (11%), (4) lack of information (9%), and (5) 
emotional factors (7%)” (Au-Yeung, 2011, p 277). 
Review of Literature 
This section included a comprehensive review of the literature related to treating 
bacterial vaginosis and medication adherence. A literature search was done with multiple 
search engines that included full texted articles from Cumulative Index of Nursing and 
Allied Health Literature (CINAHL), OVID, and MEDLINE.  Key words used in the 
literature search included etiology, bacterial, vaginosis, treatment, metronidazole, 
clindamycin, adherence, and recurrence. No restrictions were given to dates; all articles 
were written in English and published in peer reviewed journals. 
Etiology of Bacterial Vaginosis 
The cause of bacterial vaginosis continues to raise questions and remains to be 
poorly understood (Marrazzo, Thomas, Fiedler, Ringwood, & Fredricks, 2010; Chen et 
al., 2009; Koumans et al., 2007; Menard, 2011; CDC, 2012).   Bacterial vaginosis is a 
synergistic infection involving multiple bacteria. (Marrazzo et al., 2010: Menard, 2011). 
Patients diagnosed with bacterial vaginosis commonly have complaints of malodorous 
discharge and an increase in vaginal pH flora (Koumans et al., 2007, Elkins, & Mayeaux, 
2010.)  The exact reason for the rise in the pH remains a mystery to researchers (Kumer 
et al., 2011). The vagina continues to be a complex system making women prone to 
bacterial vaginosis (Kumer et al., 2011).  Many researchers have classified bacterial 
vaginosis as a sexually transmitted infection (Turovskiy, Sutyak, & Chikindas, 2011, 
Menard, 2011; Cherps, Hillier, Meyn, Busch & Krohn, 2008).  Socioeconomic status, 
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multiple sex partners, same sex relationships, douching, smoking, medications, and lack 
of condom use are several factors which predispose women to bacterial vaginosis 
(Klebanoff et al., 2010; Koumans, et al., 2007; CDC, 2012; Menard, 2011). 
Diagnosis of Bacterial Vaginosis 
The diagnosis of bacterial vaginosis  is made if  three of four of the following 
symptoms known as Amsel’s criteria are present: “a thin homogenous vaginal discharge, 
vaginal pH greater than 4.5, fishy amine odor when vaginal discharge is mixed with a 
10% potassium hydroxide solution (a positive whiff test), and presence of clue cells 
which are epithelial cells with Gram negative polymorphic-bacterial rods attached to their 
surface on microscopic examination” (Menard, 2011, p 297; Donders, 2010; Nugent, 
Krohn  & Hillier, 1992). Bacterial vaginosis can be asymptomatic in about 50% of 
women, and for that reason microbiological diagnostic method is necessary, such as 
Nugent’s scoring system (Menard, 2011; Donders, 2010; Nugent, et al., 1992). Bacterial 
vaginosis is diagnosed using a score applied to gram stains of vaginal fluid and the 
Nugent criteria or scoring system. The gold standard for microscopic evaluation of 
vaginal discharge for the diagnosis of bacterial vaginosis is Nugent’s scoring system.  
(Nugent et al., 1992, Elkins, & Mayeaux, 2010).   Menard (2011, p 297) stated there must 
be a certain number of  lactobacilli and associated bacterial morphotypes required to 
create a scale of clear abnormality ranging from normal (score = 0 to 3) through 
intermediate (score = 4 to 6) to frank bacterial vaginosis (score = 7 to 10)”. Nugent’s 
scoring system must equal 7 or greater for the diagnosis of bacterial vaginosis to be given 
(Menard, 2011).  
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Treatment Regimens Antibiotic Therapy 
This review of the literature continues found that currently, intra-vaginal and oral 
formulations of the antibiotics clindamycin and metronidazole continues to be the 
recommended formulations for the treatment of bacterial vaginosis (Chen et al., 2009; 
Bradshaw, Morton, & Hocking, 2006; Menard, 2011; CDC, 2012). However, oral 
metronidazole remains the drug of choice among clinicians and the CDC due to its 
efficacy (CDC, 2012). However, most practitioners are aware of the common 
gastrointestinal side effects when prescribing systemic metronidazole (CDC, 2012).  
Metronidazole Treatment 
 Since the early 1980s, metronidazole has been used widely in the treatment of 
bacterial vaginosis with good clinical results.  The CDC has recommended metronidazole 
as the first line of treatment for bacterial vaginosis (CDC, 2012: Menard, 2011). 
Metronidazole is the drug of choice among clinicians and recommended by the CDC 
protozoa infections and other aerobic infections (Lofmark, Edlund, & Nord, 2010).  Oral 
and vaginal preparations of Metronidazole and Clindamycin have been studied 
extensively for the treatment of bacterial vaginosis (Chen et al., 2009; Menard, 2011; 
Bunge, Beigi, Meyn, & Hiller, 2009). 
Hanson et al., 2000 and Ransom et al., 1999, compared the efficacy of oral 
metronidazole (500 mg) take by mouth twice daily and vaginal metronidazole gel 5 
grams 0.75 % , both studies showed the treatments to be similar  with vaginal preparation 
to have fewer side effects than oral treatments regimens. Hanson et al., 2000 & Menard, 
2011 studies discussed the criteria for what defines cure and treatment failures for 
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bacterial vaginosis. Several studies have shown that 31%  of patients treated with vaginal 
preparations for bacterial vaginosis have fever gastrointestinal side effects compared to 
52 % or oral treatment regimens (Hanson, et al., 2000, Menard, 2011).  
The cure rate for the treatment using clindamycin and metronidazole (Flagyl) has 
been shown to achieve cure rates of 91-92 % in cases after two weeks of treatment 
(Oduyebo et al., 2009). In 2007 Schwebe and colleagues discovered that treatment 
utilizing 2 gram of metronidazole for the treatment of bacterial vaginosis had the lowest 
cure rates and is no longer recommended. A more recent review also concluded that the 
“seven day regimen of metronidazole is superior to the single dose regimen leading 
authors to recommend it as the first line regimen in the treatment of bacterial vaginosis” 
(Menard, 2011, p 297). Metallic taste, gastrointestinal symptoms nausea, vomiting and 
candida infections have been associated with the use of oral metronidazole (CDC, 2012; 
Menard, 2011; Oduyebo, Anorlu, Ogunsola, 2009).  Vaginal preparations of 
metronidazole (Metro gel) have fewer side effects than oral metronidazole (Menard, 
2011). 
Clindamycin Treatment 
The second line of antimicrobial medication used for the treatment of bacterial 
vaginosis is Clindamycin (Faro & Skokos, 2005; Menard, 2011). Clindamycin regimens 
have several preparations for the treatment of bacterial vaginosis including oral and 
vaginal preparations (cream and ovules) (Faro & Skokos, 2005; Menard, 2011). Only one 
study was found that evaluated the use of oral clindamycin versus vaginal clindamycin.  
Treatment using oral clindamycin of 450 mg three times a day and vaginal clindamycin 
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cream had similar cure rates (Faro & Skokos, 2005).  In a recent Cochrane review five 
gram 2% clindamycin vaginal cream (5 gr) at bedtime for seven days; 100 milligram 
(mg) ovule daily for three days or 500 mg oral clindamycin twice daily for seven days 
appears to have equivalent efficacy to 500 mg oral clindamycin twice daily for seven 
days or topical five gram 0.75% metronidazole gel daily for seven days (Oduyebo et al., 
2009, p). However, topical clindamycin tends to cause lower adverse effects (metallic 
taste in the mouth, nausea, and vomiting), than oral metronidazole (Menard, 2011). 
Clindamycin creams and ovules are oil based which interferes with condom and 
diaphragm safety (Menard, 2011). 
Recurrence of Bacterial Vaginosis 
Several studies have shown that relapse is frequent after antibiotic therapy (Chen 
et al., 2009; Reichman, et al. 2010; Bunge, et al., 2009).  The treatment of asymptomatic 
women or their sexual contacts will not reduce the transmission of bacterial vaginosis and 
is not currently recommended (CDC, 2012; Menard, 2011).   The recurrence rate of 
bacterial vaginosis can be as high as 30% in 3 months to 58% 12 months after oral 
metronidazole therapy in some cases (Reichman et al., 2010; Chen et al, 2009, Menard, 
2011).  Several reasons were cited for treatment failure using oral metronidazole: (a) 
“resistance to the drug of choice, (b) survival of bacteria on the vaginal epithelium (c) 
possible re-infection from not abstaining from sex or using condoms during treatment” 
(Menard, 2011, p. 302-303). Kirpalani et al., (2007) the rate of non- adherence of patients 
not complying with treatment regimens may has been estimated to be 20% to 50 %. Non-
adherence can lead to increase hospitalizations, antibiotic resistance, worsening of 
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diseases, and health care cost (Osterberg & Blaschkle, 2005). Adherence or compliance 
has been called “the key mediator between medical practice and patient outcomes” 
(Kirpalani et al. 2007, p. 540).  Increasing communication between patients and health 
care professionals with simple interventions have been discussed to improve patient 
adherence (Kirpalani et al., 2007).  In a recent Cochran review database, several simple 
interventions appeared to improve adherence with short term regimens (Kirpalani et al., 
2007).  Several measures or interventions such as pill counting, electronic pill bottle caps, 
and patient diaries to improve medication use for chronic conditions have been studied 
and appear to be less effective (Kirpalani et al., 2007).  Several studies have been 
conducted regarding barriers related to patients adhering to medication treatment 
regimens and HIV antiviral treatment adherence (Brown, & Bussell, 2011; Russell, et al., 
2007; Flaks et. al 2003).   The transmission of HIV continues to be a worldwide epidemic 
(Mayer et al, 2012). Despite education and highly active antiviral HIV and AIDS 
treatment (HAART), which has been shown to decrease or slow the spread of HIV by 
decreasing the infectiousness of those treated , the spread of HIV in the US alone has 
remained unchanged during the past decade ( Mayer , 2012).    HIV treatment calls for 
strict adherence to antiviral medications.  Non-adherence to antiviral medications can 
lead to many unfavorable out comes. Research has shown that text messaging can play a 
role in notifying patients of doctors’ appointments, STI retesting, provisions of STI 
results, and help improve  and facilitate patient communication among patients and health 
care providers (Lunny et al., 2014).   
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Methods 
 A quasi-experimental approach was utilized using a comparative change model at 
two different Planned Parenthood health centers.  The project was conducted Monday 
through Saturday until the total number of participants reached 50.  The project enrolled 
50 women, ages 18-45 seen for vaginal discharge and given a diagnosis of bacterial 
vaginosis with the ICD 9 code 616. The control group:  Clinic A enrolled 25 women, 
aged 18-45 of child bearing ages, seen for vaginal discharge and given a diagnosis of 
bacterial vaginosis with the ICD 9 code 616.  These women were seen by providers and 
educators who had not received a 45-minute in-service training that covered information 
about behavior change related to type of underwear worn, type of tampons/pads worn, 
condom use, and medication adherence. The intervention group: Clinic B enrolled 25 
women, aged 18-45 of child bearing ages, seen for vaginal discharge and given a 
diagnosis of bacterial vaginosis with the ICD 9 code 616.  These women were seen by 
providers and educators who had received a 45-minute in-service training that covered 
information about behavior change related to type of underwear worn, type of 
tampons/pads worn, condom use, and medication adherence. One clinic was randomly 
selected for providers to receive the 45 minute in-service training, and the other clinic’s 
providers did not receive the in-service training. Subjects were asked to complete two 
surveys.  The first survey was administered after their diagnosis for bacterial vaginosis 
and consent obtained (Appendix A). The initial survey consisted of six questions which 
took no longer than 3-4 minutes to complete (Appendix B).  Nine to 14 days after the 
initial visit a second survey was administered by phone by the researcher. The second 
survey took less than 10 minutes and asked about medication adherence and  the same 
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behavioral changes as survey one (Appendix C). All project material was kept under lock 
and key in the health center’s managers’ office. Approximately two weeks into the 
project the primary investigator followed up with health center personnel for any 
questions and concerns regarding the project. Data was entered and analyzed using the 
SPSS program. Data was presented as frequency and percent for categorical variables and 
mean and standard deviation (or median and interquartile range where appropriate) and 
range (minimum –maximum) for continuous variables. Data was checked for normal 
distribution using the Kolmogorov-Smirnov (K-S) Test and visually examined 
histograms which revealed that all the continuous variables were skewed.  
Eligibility Criteria 
Participants  between the ages of 18 and 45; who had vaginal discharge; must not 
had been treated for bacterial vaginosis within the last month or be currently under 
treatment for bacterial vaginosis or taking any antibiotics; were not pregnant; were not 
allergic to the treatment medications; and could read and speak English were eligible to 
be in the study. 
Stakeholders 
 The stakeholders for this pilot project consisted of patients, health center 
clinicians, educators and insurance companies. The World Health Organization (WHO) 
has adopted different views as to what constitutes a disparity.  Ethnicity, sex and quality 
of and/or access to care when treating patients were several disparities discussed by the 
World Health organization (American College of Physicians, 2010).  Major stakeholders 
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such as health care providers and insurance companies agreed that such disparities are 
unjust and need to be addressed by (American College of Physicians, 2010). Medical and 
clinical outcomes were affected by all of the stakeholders involved when treating 
bacterial vaginosis. Increased health care cost, death and worsening of disease have been 
attributed to non-adherence of medication treatment regimens (Osterberg & Blaschkle, 
2005). All stake holders were important in increasing patient knowledge regarding the 
transmission of bacterial vaginosis and its treatment regimens. Advanced Practice Nurses 
provided evidence based treatment regimens and education to the patients they serve.  
Accountably is ultimately up to patients to adhere to medication and treatment regimens 
(Osterberg, & Blaschkle, 2005).   As stated by the former Surgeon General C. Everett 
Koop “drugs don’t work if patients don’t take them” (Osterberg, & Blaschkle, 2005, p 
487).  When patients adhere to medication regimens patients are healthier and there is a 
decrease in hospital costs and admissions. 
Challenges to Project 
The challenges to the project were the small sample size and conducting the 
project only within two Midwest Health Care Centers. Lower social economic status 
and/or population, educational level, age and race were additional challenges to the 
project. Other challenges the project  faced when measuring outcomes included the  use 
of female feminine products (pads or tampons), the association of bacterial vaginosis 
with birth control methods, types of underwear (cotton or silk), and menstrual cycles 
(Klebanoff et al., 2010; Menard, 2011: Koumans et al., 2007). Another challenge 
included data collected through self- report and patients  possibly not being truthful with 
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the providers regarding taking their medications or their sexual and hygiene behaviors. 
Several rationales to results obtained from the project may be related to (1) Are the 
clinicians and health educators using pre/post questionnaires the same way all the time? 
(2) Are all clinicians and health educators receiving the same education and are they 
educating their patients in similar ways?  (3) How will new employees be educated? (4)  
How will the investigator track the movement of employees within the establishments?   
Application to Practice 
The results of this project will be disseminated and discussed with the Advanced 
Practice Nurses and health center directors involved in the project. This project will be 
helpful for the Advanced Practice Nurses when discussing drug regimens and plans of 
care by increasing the patients’ knowledge and education regarding the transmission of 
bacterial vaginosis. This project encouraged positive changes by both the providers and 
patients by using evidence based discharge sessions.  Behavioral changes made by the 
patients involved in the study will inevitably increase medication adherence and decrease 
the risk of acquiring bacterial vaginosis.   This clinical project had an inter-professional 
collaboration among providers APRNs and stake holders by using evidence based 
practice and education which helped increase patient’s knowledge regarding bacterial 
vaginosis and its treatment regimens. 
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Theoretical Framework 
Many people are apprehensive to change. However, change can bring out the best 
in individuals. There were many ways of implementing change throughout this clinic 
project.  Kurt Lewins’ theoretical framework ‘Change Theory” guided this clinical 
project. Schifalacqua et al. (2009) and his colleagues state that Lewins’ changed method 
will be adapted, when there is a plan, a purpose, and collaboration among those involved. 
Lewin’s Change theory addressed how and why change occurs.  In 1951 Kurt Lewin 
explained that in order for change to take place there are three steps the agent must go 
through (Figure 1).  
 
 
Fig.1 Lewin's Theory of Change 
Unfreezing was the 1
st
 step: change was needed. The advanced nurse practitioners 
and health center educators were in-serviced on up to date evidence based practices on 
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bacterial vaginosis. In the unfreezing phase the advanced practice nurse and health center 
educators challenged patients beliefs (“scented tampons or pads”) will make sure I won’t 
have a vaginal odor while on my menses”), attitudes (“I don’t have to use condoms 100 
%”) and norms “(it’s normal to douche; everyone douches after their menstrual cycle”). 
Moving/Change is the second step of the Change Theory: change had been initiated. In 
order for the change to be successful patients believed change was needed. Advanced 
nurse practitioners and health center educators reevaluated their teaching by giving 
patients a post questionnaire by phone call between days 9-14 after their initial visits. 
Medical providers educated patients on ways to decrease or minimize their risk on 
acquiring bacterial vaginosis ex. (a) increasing condom usage (b) reducing the use of 
scented feminine products during their menstrual cycles, (c) decreasing douching  and (d) 
increasing the  percentage of wearing cotton underwear throughout the month. Refreezing 
took place after equilibrium had been established, which was the last phase or step to the 
Change Theory. Patients understood with behavioral changes such as no douching, no 
thongs or non-cotton type underwear, 100% usage of condoms, and 100% compliance 
with medication would decrease their risk of acquiring or having a recurrence of bacterial 
vaginosis.    
Gaps in Nursing Science 
As discussed by Marrazzo, et al. (2010, p. 740) there were several outstanding 
questions that warrant further investigation: (a) “What is normal clinically, 
microbiologically, and immunologically? (b) What was considered normal for the human 
vagina? (c) Which bacterial or bacterial community types were associated with bacterial 
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vaginosis?” A major limitation of several studies of the vaginal microbiota is their failure 
to use any objective method such as Amsel’s or Nugent criteria to assess for bacterial 
vaginosis (Marrazzo et al., 2010).  No studies or reviews were found that discussed 
medication adherence when treating bacterial vaginosis. However, there were several 
studies regarding medication adherence when treating HIV, chlamydia and gonorrhea 
infections (Lunny et al, 2014).   There appeared to be gaps in nursing research regarding 
compliance when treating bacterial vaginosis.  
Research Question 
The research question to be answered was there a greater increase in patients’ 
knowledge and behaviors in the intervention group regarding bacterial vaginosis and 
medication adherence, as compared to the comparison group? 
Project Design 
Instruments /Tool Development 
There are no programs at the present to follow, therefore an appropriate 
instrument to measure clinicians and patients’ knowledge was adapted and modified to 
questions by the lead investigator. Medication adherence was measured using a 
questionnaire modified by the primary investigator, Patients’ Medication Adherence 
Questionnaire (see Appendix D). All surveys developed were written on at or below 
fourth grade level.  The medication adherence questionnaire was modified to be 
appropriately used with the project for timing of data collection and constraints to the 
project.  Validity was assessed by making sure all goals and objectives were clearly 
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defined. Staff members were surveyed and asked to look over the questionnaires for 
troublesome wording, readability and/or understanding, comments, concerns and/or 
suggestions. 
Data Analysis 
A total of 50 women participated in the study which included pretest, posttest, and 
adherence questions analyzed at first with Univariate analysis. Data were presented as 
frequency and percent for categorical variables and mean and standard deviation (or 
median and interquartile range where appropriate) and range (minimum –maximum) for 
continuous variables. Data were checked for normal distribution using the Kolmogorov-
Smirnov (K-S) Test and visually examining histograms which revealed that all the 
continuous variables were skewed. Thus the Mann Whitney test, ranks data from low to 
high, rather than using exact values, was used instead of the independent samples t-test. 
The group with the highest mean rank has the highest scores and vice versa.   The median 
measure was used for the adherence score given the skewed nature as indicated by the 
significant K-S test. A p-value of 0.05 was considered statistically significant. Since only 
5% of the study participants had menstrual cycles since their last visit, not enough data 
was available to analyze usage of scented feminine products. Since 30% of the study 
population reported sexual activity since their last visit, not enough data was available to 
analyze condom usage. The distribution of adherence score is the same across categories 
of the intervention using the Mann-Whitney U Test (non-parametric equivalent of the 
Students t-test). All data was analyzed using SPSS statistical package (version 20.0, 
SPSS Inc., Chicago, IL, USA).  
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Table 1. Pre-Test Univariate Analysis by Intervention Status (n=50) 
 
Contro
l  
Interventio
n 
Question (n=25) (n=25) 
In the Past 3 months how often have you used condoms?   
    Always 3(12) 4(16) 
    Sometimes 10(40) 7(28) 
    Never 12(48) 13(52) 
Last time you had sex did you use condoms? (yes) 6(24) 7(28) 
During last menstrual cycle did you use any scented feminine 
tampons or pads? (yes) 6(24) 3(12) 
In last 30 days, how many days did you wear thong underwear?
 †
 0(0) 0(0) 
    Range (days) 0-20 0-15 
In last 30 days, how many days did you wear cotton underwear?
 †
 30(0) 30(2) 
    Range (days) 10-30 15-30 
In last 30 days, how many days did you douche?
 †
 0(0) 0(1.50) 
    Range 0-3 0-4 
Results are presented as Frequency and Percent unless denoted. 
† Results presented as median and interquartile range. 
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Table 2. Post-Test Univariate Analysis by Intervention Status (n=50). All Questions 
pertain to the last 9-14 Days 
 Control  Intervention 
Question (n=25) (n=25) 
Have you had sex since your visit to the health clinic? (yes) 6(24) 8(38) 
    How many times? 2.00(2.50) 2.00(0.50) 
        Range (days) 1-4 2-4 
    How often did you use a condom?   
        Always 1(17) 2(29) 
        Sometimes 3(50) 4(14) 
        Never 2(33) 1(14) 
Have you had a menstrual cycle? (yes) 1(4) 2(8) 
    Did you use any scented feminine tampons or pads? (yes) 1(100) 0(0) 
How many days have you worn thong underwear?
 †
 0(0) 0(0) 
    Range (days) 0-9 0-2 
How many days have you worn cotton underwear?
 †
 9(0) 9(0) 
    Range (days) 0-9 7-9 
Have you douched since your last visit to the health clinic? 
(yes) 1(5) 4(20) 
    How many times have you douched?
 †
 0(0) 0(0) 
        Range (days) 0-2 0-2 
Results are presented as Frequency and Percent unless denoted. 
† Results presented as median and interquartile range. Adherence of wearing thong and 
cotton underwear was assessed using Fisher’s Exact Test. Numbers do not add up to 50 
due to loss at follow up. 
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Table 3. Post-Test Adherence Univariate Analysis by Intervention 
Status (n=45).  
 Control  Intervention 
Question (n=20) (n=25) 
In the last 9-14 days since your visit to health 
center have you forgotten to take your Flagyl or 
Metro gel? (yes) 16(64) 6(24) 
Over the past 7 days, were there any days when 
you did not take your Flagyl or Metro Gel 
Medicine?(yes) 16(64) 6(24) 
Have you ever stopped or cutback on taking your 
Flagyl or Metro Gel without telling your 
healthcare provider because it made you feel 
worse? (yes) 25(100) 17(71) 
Did you take all of your doses of Flagyl or Metro 
Gel yesterday? (yes) 22(88) 23(92) 
When you feel like your symptoms are under 
control, do you sometimes stop taking your Flagyl 
or Metro Gel medicine? (yes) 25(100) 19(79) 
Do you sometimes feel hassled about sticking to 
your treatment plan? (yes) 25(100) 20(83) 
How often do you have difficulty remembering to 
take all of your Flagyl or Metro Gel?    
    Never/Rarely 0(0) 4(17) 
    Once in a while 4(16) 6(25) 
    Sometimes 10(40) 7(29) 
    Usually 6(24) 3(13) 
    All the time 5(20) 4(17) 
Total Score
†  (median, SD, max, min)
 7(2) 5(3)* 
   Range (points) 5-7 0-7 
Low Adherence 25(100) 19(76)** 
Results are presented as Frequency and Percent unless denoted. 
† Results presented as median and interquartile range.  
Number does not equal 50 due to 5 participants were lost due to follow up.  
Control Group (median = 7.00, SD = .943, Min = 5, max = 7, p < .002) 
Intervention Group ( median =5.00, SD = 2.219, min = 0, max = 7, p > .035) 
*p-value for Mann-Whitney U < .002 
**p-value for chi-square = .035 
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Results 
The control group showed a lower range on three of the questions relating to 
wearing of cotton or thong underwear and douching before in-servicing was provided to 
the intervention group of Advanced Nurse Practitioners and health care providers (see 
table #1). 
The intervention group had a lower median adherence score as calculated in the 
Mann-Whitney U test, compared to the control group (p<.002). The intervention group 
had better adherence to their Flagyl and Metro Gel medication. The median measure was 
used for the adherence score given the skewed nature as indicated by the significant K-S 
test. A p-value of 0.05 was considered statistically significant (see table #3).  
  Adherence of wearing thong and cotton underwear was assessed as a yes/no 
variable by intervention status; differences between the two groups were assessed using 
Fisher’s Exact Test instead of Pearson’s Chi-Square given small cell size.  There was no 
significant difference between the intervention and control group (p>0.05) in regards to 
wearing of thong or cotton underwear (see table #2). 
 Only 5% of the study participants reporting having had a menstrual cycle since 
their last visit, not enough data were available to analyze usage of scented feminine 
products. With only 30% of the study population reporting sexual activity since their last 
visit, not enough data was available to analyze condom usage. 
Increasing Patients’ Knowledge  Garner, Debra, 2014, UMSL, 30. 
 
Post- Test Adherence Intervention Status 
Data analysis of the adherence was analyzed by their clinic allocation (intent to 
treat analysis) following analysis of the post -test adherence, seven of the nine questions 
retained to the primary investigators null hypothesis that there would be a greater effect 
on the intervention group receiving education from health care providers.  The analysis of 
the total score and low adherence between the control and intervention group reject the 
null hypothesis were evaluated with Mann-Whitney U and chi-square, respectively, with 
as both have a p value <.05 (p < .002 and p =.035, respectively). The median adherence 
score for the control group was 7, and the median adherence score for the intervention 
group was 5.00.  Since lower scored indicate better adherence, the intervention group 
adhered significantly more than the control group.  
Conclusion 
The project showed that after an educational in-service with the Advanced 
Practice Nurses and health educators there was an increase in patients’ knowledge 
regarding the transmission of bacterial vaginosis and adherence to treatment regimens, as 
compared to the control group, whose providers had not received the in-service.  The lead 
investigator will disseminate the findings to the medical director, lead clinician, and 
health center staff.  The findings of the study will be submitted as a poster presentation at 
the national Family Planning conference. This project can be replicated in the other 
family planning facilities or similar health centers by in-servicing the health care 
providers and educators on current evidence based practice, developing protocols for 
treatment of bacterial vaginosis and educating patients’ on behaviors associated with 
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increased chances of contracting bacterial vaginosis. Increasing clinician and patient 
knowledge regarding bacterial vaginosis, behavioral changes, and medication adherence 
were important key factors for the success of this project.  
Essentials to DNP Practice 
The development of a professional doctorate program for nursing has been in the 
works for decades (Chism, 2010).  Many have raised the question since the development 
of the DNP program, what exactly is the Doctor of Nursing Practice (DNP) degree? 
(Chism, 2010).  As stated by Chism (2010) the “Doctoral education in nursing is 
connected to our past and influences the directions we may take in the future”, (Chism, 
2010 p. 3).  Doctoral prepared clinicians will be better prepared to handle the more 
critically ill and underrepresented patients and provide higher quality care utilizing 
evidence based measures. As nurse practitioners further their education and clinical 
practice, they will help to bring such process bring about positive changes in health status 
which affects practice and education at the doctoral level.  Such positive changes help to 
increase patients’ knowledge regarding behavioral and changes to help decrease their risk 
of acquiring bacterial vaginosis and improving medication adherence. The DNP 
essentials used to guide this project were the “Scientific Underpinnings for Practice and 
Inter-professional Collaboration for Improving Patient and Population Health Outcomes 
and Clinical Scholarship and Analytic Methods for Evidence –Based Practice (Chism, 
2010). DNP Essential I, Scientific Underpinnings for Practice and Inter-professional 
Collaboration for Improving Patient and Population Health Outcomes were met by 
collaboration among the primary investigator and other health clinicians to help patients 
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improve medication adherence when treating bacterial vaginosis and identifying 
behavioral changes to decrease the risk of acquiring bacterial vaginosis.  DNP Essential 
III was met by incorporating evidence based literature and discharge instructions to 
patients and in-servicing health care providers on up to date treatment regimens. The 
project main goals were met by increasing medication adherence and encouraging 
positive behavioral changes by patients.  
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Appendix A 
Consent Form 
Study Title:  Increasing Patients Knowledge in Transmission of 
Bacterial Vaginosis and its Treatment Regimens 
Principal Investigator:  Debra Pikes, BC-FNP 
Address:   Planned Parenthood    Planned Parenthood 
West County Health Center North County 
 Stonegate Center #1 2796-98 N. Hwy 67 
Manchester, MO 63088 Florissant, Mo. 63033 
  
 
    
Introduction: You are being asked to participate in this clinical project to assess 
patient’s knowledge regarding bacterial vaginosis and medication adherence. After 
reading this form, you can decide to be in the project or you can decide not to be in the 
project.  Either choice is OK.  
Participants Status: This project is strictly voluntary and I may stop participation at any 
time.  
Study Goals: The project will evaluate patients’ knowledge regarding behavioral 
changes and adherence to medications when treating bacterial vaginosis.  
Sample collection: Collection of vaginal discharge using a clean unlubricated speculum 
and evaluation of vaginal discharge by microscope will be performed by a trained nurse 
practitioner.   
Procedures: All patients participating in the project will be asked to complete a pre and 
post questionnaire regarding their knowledge pertaining to behavioral practice, treatment 
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regimens of bacterial vaginosis and medications prescribed. Patients will be followed up 
with a phone call at approximately 9-14 days after their visit. 
Confidentiality Pledge: All information will be kept confidential and only shared with 
those involved in analyzing the questionnaires, Midwest Health Centers Directors and 
Advanced Nurse Practitioners and the University of Missouri Committee members. The 
Electronic medical records will be accessed only to retrieved data for the project. All 
project participants will be identified by their medical record number. 
Compensation: I agree that if I participate in this project I will not be compensated for 
my time. 
Potential Risk: The potential risk involved in this project may be discomfort while 
receiving a pelvic exam, increase risk for infection or potential false positive test results. 
Participant Selection: If you agree to take party in this project, you will be one of about 
50 subjects taking part at two family planning clinics. To be included in this project, you 
must currently have vaginal discharge; must be at least 18 years of age but no older than 
45 years old, must not have been treated for bacterial vaginosis within the last month or 
currently under treatment or taking any antibiotics, not pregnant, allergic to the treatment 
medications, able to read and speak English. 
Contact Information: If at any time during this study you have any questions or 
concerns the investigator may be reached at: DP469@umsl.edu 
_____________________________  ________________________ 
Subject Signature    Date 
_____________________________  _________________________ 
Signature of Witness/Investigator  Date 
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Appendix B 
Bacterial Vaginosis Pre-Questionnaire 
 
MRN_________________________ Date of Service_________________ 
1. In the past 3 months how often have you used condoms?                                        
 (a) always  (b) sometimes  (c) never 
2. Last time you had sex did you use condoms?      
   (a) yes  (b) no 
3. During your last menstrual cycle did you use any scented feminine tampons or 
pads?  (a) yes  (b) no 
4. In the last thirty (30) days, how many days did you wear thong underwear? 
5. In the last thirty (30) days, how many days did you wear cotton underwear? 
6. In the last thirty (30) days, how many times did you douche?  
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Appendix C 
 
Bacterial Vaginosis Questionnaire    
MRN_________________________ Date of Service______________________ 
Post follow up date __________________ 
1. In the last 9-14 days have you has sex since your visit to the health clinic?  
   (a)yes   (b) no 
2. If yes, how many times? And how often have you used condoms with sex?  
 (a) always (b) sometimes (c) never 
3. In the last 9-14 days have you had a menstrual cycle? 
   (a) Yes  (b) no  
4. If yes, did you use any scented feminine tampons or pads?   
   (a) yes  (b) no 
5. In the last 9-14 days since your visit to the health clinic how many days have 
you worn thong underwear? 
6. In the last 9-14 days since your visit to the health clinic how many days have 
you worn cotton underwear?  
7. In the last 9-14 days have you douched since your visit to the health clinic?  
   (a) yes  (b) no   
8. If yes, how many times have you douched? 
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Appendix D 
 
MRN____________________   
Patient Post medication Questionnaire___________________ 
Date of Follow up_________________________ 
Question    Patient Answer    Score 
     (Yes / No)     Y = 1 N = 0 
1. In the last 9-14 days since your visit to the health center have you forgotten to 
take your Flagyl or Metro gel medication?    
Yes / No 
2. People sometimes miss taking their medicines for reasons other than forgetting. 
Thinking over the past 7 days, were there any days when you did not take your 
Flagyl or Metro Gel medicine? 
Yes/ No 
3. Have you ever stopped or cut back on taking your Flagyl or Metro Gel medication 
without telling your health care provider because it made you feel worse? 
Yes/No  
4. Did you take all of your doses of Flagyl or Metro Gel yesterday? 
Yes/No 
5. When you feel like your symptoms are under control, do you sometimes stop 
taking your Flagyl or Metro Gel medicine? 
Yes/No 
6. At times taking medication can be a real inconvenience for some people. Do you 
sometimes feel hassled about sticking to your treatment plan?  
Yes /No 
7. How often do you have difficulty remembering to take all of your Flagyl or Metro 
Gel? 
A=0  B-E=1 
___ A. Never/rarely 
__  B. Once in a while 
__  C. Sometimes 
__  D. Usually 
__ E. All the time 
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Total Score:  Scores: >2 = low adherence 1 or 2 = medium adherence 0 = high 
adherence 
